Bonyan, a leading Egyptian real estate investment platform focusing on offices, logistics, and retail, acquires and operates commercial assets with high potential for appreciation and income, with a strategy of taking a long position on the USD. Bonyan was acquired by Compass Capital in 2018, with only a single asset. The asset, named Designopolis, was originally developed as a specialty furniture mall designed by renowned architectural firm Skidmore, Owings and Merrill and located in the Sheikh Zayed area of West Cairo. Compass led the re-purposing of the asset, turning into a complete lifestyle destination including retail, F&B and offices. Bonyan then strategically expanded its portfolio through a series of acquisitions including a portfolio of buildings from Namaa in 2022 and a Redcon property in 2024, bringing their East and West Cairo portfolio to eight grade A assets with a total BUA of 138,000 sqm.

In 2011, Compass Capital led a consortium that acquired 100% of the Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda), a leading Egyptian pharmaceutical company with a broad portfolio of human and veterinary products. Compass Capital’s specific initiatives have enabled the company to achieve significant milestones. Rameda has consistently outperformed the top 15 pharmaceutical players in Egypt in terms of revenue growth on the back of its aggressive expansionary strategy. Rameda has successfully built a scalable platform supported by three primary pillars of people, product and production. The company boasts an encouraging pipeline of new molecules in attractive therapeutic areas through 37 bolt-on molecule acquisitions, has completed its second expansion drive which increased capacities and is led by a capable and experienced management team that can deliver results. In December 2019, Rameda started trading under the ticker name RMDA on the Egyptian Stock Exchange, and the transaction was advised by CI Capital, Investec and HSBC.